Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-20-041452
Filing Date
2020-02-19
Accepted
2020-02-19 09:32:58
Documents
4
Period of Report
2020-02-19

Document Format Files

Seq Description Document Type Size
1 6-K d886556d6k.htm 6-K 9768
2 EX-10.1 d886556dex101.htm EX-10.1 95315
3 EX-10.2 d886556dex102.htm EX-10.2 75904
4 EX-99.1 d886556dex991.htm EX-99.1 16953
  Complete submission text file 0001193125-20-041452.txt   198963
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Filer) CIK: 0001719714 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38452 | Film No.: 20627778
SIC: 2834 Pharmaceutical Preparations